Early Outcomes Using Hepatitis C-Exposed Donors for Cardiac Transplantation in the Era of Effective Direct-Acting Antiviral Treatments

K. Schlendorf,S. Zalawadiya,A. Shah,M. Wigger,C. Chung,M. Danter,M. Keebler,D. Brinkley,J. Menachem,S. Brown Sacks,H. Ooi,R. Perri,J. Awad,S. Smith,R. Hayes, H. O'dell,C. Darragh,A. Carver, C. Edmonds,S. Ruzevich-Scholl,J. Lindenfeld

JOURNAL OF HEART AND LUNG TRANSPLANTATION（2018）

引用 2|浏览13

暂无评分

摘要

The shortage of suitable donors for heart transplantation (HT) contributes to wait-list mortality and increased reliance on mechanical circulatory support. Considering this need, and the favorable drug profiles and efficacy of current agents used to treat Hepatitis C (HCV), our institution is now transplanting selected patients using HCV-exposed donors.

查看译文

关键词

cardiac transplantation,donors,c-exposed,direct-acting

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要